Last reviewed · How we verify

NCT05320718

Analgesia in Minimally Invasive Direct Coronary Artery Bypass Grafting: Programmed Intermittent Bolus Infusions of Erector Spinae Plane Block Versus Paravertebral Block

Completed NA Last updated 8 January 2025
What this trial tests

NA trial testing Ropivacaine in Regional Anesthesia in 140 participants. Completed in 30 December 2023.

Timeline
1 March 2022
Primary endpoint
30 June 2023
30 December 2023

Quick facts

Lead sponsorPeking University Third Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment140
Start date1 March 2022
Primary completion30 June 2023
Estimated completion30 December 2023
Sites2 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking University Third Hospital

Who can join

Adults 18 to 75, any sex, with Regional Anesthesia or Anesthesia, Local. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Paravertebral block (PVB) has been regarded as effective regimen for pain control after cardiac surgery. As a novel analgesia technique, erector spinae plane block (ESPB) has been reported to provide effective analgesia after thoracic and cardiac surgery. We hypothesized that the ESPB is non-inferior to PVB in treating pain in minimally invasive direct coronary artery bypass surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ropivacaine

Trials testing the same drug.

Other recruiting trials for Regional Anesthesia

Currently open trials in the same condition.

Other Peking University Third Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05320718.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing